IP Library Granted Patent US 11,252,975
Granted Patent B2
US 11,252,975 · App. 16/650,022 · Granted Feb 22, 2022

Caffeine production method

Inventors: Julien Philippe Nicolas Mahieux (Jougne, FR); Stefan Palzer (Lausanne, CH); Gerhard Niederreiter (Vevey, CH); Laurent Forny (Lausanne, CH); Federico Mora (Morges, CH); Bruno Edgar Chavez Montes (Lausanne, CH); Laure Poquet (Servion, CH); Heiko Oertling (Lausanne, CH)
Assignee: Societe des Produits Nestle S.A.
A23F5/206B01D9/005B01D11/0288C07D473/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,252,975
App. No.
16/650,022
Granted
Feb 22, 2022
Kind
B2
Abstract

The present invention provides a method for producing caffeine, wherein the method comprises: (a) combining a coffee extract comprising caffeine with an aqueous organic acid; (b) crystallizing the coffee extract and the aqueous organic acid so as to form caffeine-organic acid co-crystals in an aqueous phase; (c) separating the caffeine-organic acid co-crystals from the aqueous phase; and (d) extracting caffeine from the co-crystals obtained in step (c), wherein step (d) comprises placing the co-crystals in an aqueous solution so as to form a caffeine precipitate and a solution comprising the organic acid. Also provided is a method for producing a decaffeinated coffee extract comprising chlorogenic acids.

Claims (25)

1. A method for producing caffeine, wherein the method comprises:

a. combining a coffee extract comprising caffeine with an aqueous organic acid;

b. crystallizing the coffee extract and the aqueous organic acid so as to form caffeine-organic acid co-crystals in an aqueous phase;

c. separating the caffeine-organic acid co-crystals from the aqueous phase; and

d. extracting caffeine from the co-crystals obtained in step (c);

wherein step (d) comprises placing the co-crystals in an aqueous solution so as to form a caffeine precipitate and a solution comprising the organic acid.

2. The method according to claim 1 , wherein the solution in step (d) is a basic solution with a pH of about 10 to about 14.

3. The method according to claim 1 , wherein step (d) further comprises re-crystallizing caffeine and separating the caffeine crystals from the solution.

4. The method according to claim 3 , wherein the placing of the co-crystals in the solution is carried out at least 5 minutes before re-crystallizing caffeine.

5. The method according to claim 1 , wherein the method further comprises drying the aqueous phase separated from the co-crystals in step (c) so as to form a dried decaffeinated coffee extract.

6. The method according to claim 1 , wherein the method further comprises adding the caffeine extracted in step (d) to a food or beverage product.

7. The method according to claim 1 wherein the method further comprises combining the caffeine extracted in step (d) with at least one of a pharmaceutically acceptable carrier, diluent or excipient to form a pharmaceutical composition.

8. A method for producing a decaffeinated coffee extract comprising chlorogenic acids, wherein the method comprises:

a. combining a coffee extract comprising caffeine and chlorogenic acids with an aqueous organic acid;

b. crystallizing the coffee extract and the aqueous organic acid so as to form caffeine-organic acid co-crystals in an aqueous phase; and

c. separating the caffeine-organic acid co-crystals from the aqueous phase so as to form an aqueous decaffeinated coffee extract comprising chlorogenic acids; and drying the decaffeinated coffee extract comprising chlorogenic acids.

9. The method according to claim 8 , wherein the coffee extract has a caffeine content of at least about 10 wt %.

10. The method according to claim 8 , wherein the coffee extract has a caffeine content of about 10 wt % to about 90 wt %.

11. The method according to claim 8 , wherein the coffee extract is a by-product or side-stream from a coffee decaffeination process.

12. The method according to claim 8 wherein the organic acid is selected from the group consisting of a hydroxybenzoic acid, a derivative of a hydroxybenzoic acid, a derivative of cinnamic acid and mixtures thereof.

13. The method according to claim 8 , wherein the organic acid is a hydroxybenzoic acid.

14. The method according to claim 1 , wherein the organic acid is selected from the group consisting of salicylic acid, gallic acid, vanillic acid, 3-hydroxybenzoic acid, 4-hydroxybenzoic acid, 2,3-dihydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 2,4-dihydroxyb enzoic acid, 2,5-dihydroxybenzoic acid, 3,4-dihydroxybenzoic acid, ellagic acid, caffeic acid, ferulic acid, p-coumaric acid and mixtures thereof.

15. The method according to claim 14 , wherein the organic acid is selected from the group consisting of salicylic acid, gallic acid, vanillic acid, 3-hydroxybenzoic acid, 4-hydroxybenzoic acid, 2,3-dihydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 2,4-dihydroxybenzoic acid, 2,5-dihydroxybenzoic acid, 3,4-dihydroxybenzoic acid and mixtures thereof.

16. The method according to claim 1 , wherein the organic acid is a hydroxybenzoic acid.

17. The method according to claim 16 , wherein the organic acid is selected from the group consisting of salicylic acid, gallic acid, vanillic acid, 3-hydroxybenzoic acid, 4-hydroxybenzoic acid, 2,3-dihydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 2,4-dihydroxybenzoic acid, 2,5-dihydroxybenzoic acid, 3,4-dihydroxybenzoic acid, ellagic acid, caffeic acid, ferulic acid, p-coumaric acid and mixtures thereof.

Assignments (2)
MERGER Recorded Nov 29, 2021
From: NESTEC S.A.
To: SOCIETE DES PRODUITS NESTLE S.A.
Reel/Frame 058220/0013 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2020
From: MAHIEUX, JULIEN PHILIPPE NICOLAS; PALZER, STEFAN; NIEDERREITER, GERHARD; FORNY, LAURENT; MORA, FEDERICO; CHAVEZ MONTES, BRUNO EDGAR; POQUET, LAURE; OERTLING, HEIKO
To: NESTEC S.A.
Reel/Frame 052238/0152 →
Priority Claims (1)
EP 17193998 · Sep 29, 2017 · regional
Continuity (1)
Related Publication 20200275675A1 · Sep 3, 2020